Glucagon-like peptide-1 analog in the treatment of metabolic dysfunction-associated steatotic liver disease
DOI:
https://doi.org/10.18203/2349-3291.ijcp20262978Keywords:
Metabolic dysfunction-associated steatotic liver disease, Obesity, Glucagon-like peptide 1 analogAbstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in children with obesity. No pharmacological therapies are currently approved specifically for paediatric MASLD. A 12-year-old boy with obesity presented with persistent hypertransaminasemia and ultrasound-confirmed hepatic steatosis. After lifestyle interventions failed to improve liver enzymes, a glucagon-like peptide 1 (GLP-1) analog was initiated and titrated to 1.8 mg/day. Six months later, transaminases improved, accompanied by a 4 kg weight loss. After one year, liver enzymes normalized without adverse effects. This case supports the potential role of GLP-1 analog as a therapeutic option for paediatric MASLD, warranting further study.
References
Rinellaa ME, Lazarusb JV, Ratziud V, Francquee SM, Sanyalg AJ, Kanwalh F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966-86.
Tou AM, Panganiban J. Glucagon‐like peptide‐1 receptor agonists in pediatric metabolic dysfunction‐associated steatotic liver disease. J Pediatr Gastroenterol Nutr. 2026;82(1):146-55.
Rupasinghe K, Hind J, Hegarty R. Updates in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Children. J Pediatr Gastroenterol Nutr. 2023;77(5):583-91.
Xanthakos SA, Ibrahim SH, Adams K, Kohli R, Sathya P, Sundaram S, et al. AASLD Practice Statement on the evaluation and management of metabolic dysfunction– associated steatotic liver disease in children. Hepatology. 2025;82(5):1352-94.
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797-835.
Downloads
Published
How to Cite
Issue
Section
